Overview

Study to Compare the Safety and Tolerability of Sativex® in Patients With Cancer Related Pain

Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and tolerability of long term therapy with Sativex® and GW-2000-02.
Phase:
Phase 3
Details
Lead Sponsor:
GW Pharmaceuticals Ltd.
Treatments:
Nabiximols